Vanguard Group Inc Denali Therapeutics Inc. Transaction History

Vanguard Group Inc

  • $5.46 Trillion
  • Q3 2024

A detailed history of Vanguard Group Inc transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 11,177,234 shares of DNLI stock, worth $273 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
11,177,234
Previous 11,312,439 1.2%
Holding current value
$273 Million
Previous $263 Million 23.95%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$20.96 - $31.05 $2.83 Million - $4.2 Million
-135,205 Reduced 1.2%
11,177,234 $326 Million
Q2 2024

Aug 13, 2024
BUY
$14.96 - $23.22 $5.15 Million - $7.99 Million
344,146 Added 3.14%
11,312,439 $263 Million
Q1 2024

May 10, 2024
BUY
$15.83 - $23.35 $2.12 Million - $3.12 Million
133,810 Added 1.24%
10,968,293 $225 Million
Q4 2023

Feb 14, 2024
BUY
$16.2 - $23.18 $3.83 Million - $5.49 Million
236,702 Added 2.23%
10,834,483 $233 Million
Q3 2023

Nov 14, 2023
BUY
$20.63 - $30.17 $7.32 Million - $10.7 Million
354,798 Added 3.46%
10,597,781 $219 Million
Q2 2023

Aug 14, 2023
BUY
$23.37 - $32.96 $2.91 Million - $4.1 Million
124,490 Added 1.23%
10,242,983 $302 Million
Q1 2023

May 15, 2023
BUY
$21.91 - $32.67 $3.76 Million - $5.6 Million
171,395 Added 1.72%
10,118,493 $233 Million
Q4 2022

Feb 10, 2023
BUY
$26.28 - $33.92 $40.6 Million - $52.4 Million
1,545,067 Added 18.39%
9,947,098 $277 Million
Q3 2022

Nov 14, 2022
BUY
$25.97 - $38.53 $2.58 Million - $3.83 Million
99,530 Added 1.2%
8,402,031 $258 Million
Q2 2022

Aug 12, 2022
BUY
$20.88 - $35.19 $3.98 Million - $6.7 Million
190,471 Added 2.35%
8,302,501 $244 Million
Q1 2022

May 13, 2022
SELL
$29.0 - $47.27 $1.44 Million - $2.34 Million
-49,500 Reduced 0.61%
8,112,030 $261 Million
Q4 2021

Feb 14, 2022
SELL
$42.59 - $55.02 $296,128 - $382,554
-6,953 Reduced 0.09%
8,161,530 $364 Million
Q3 2021

Nov 12, 2021
BUY
$48.48 - $78.23 $25.4 Million - $41 Million
524,353 Added 6.86%
8,168,483 $412 Million
Q2 2021

Aug 13, 2021
BUY
$50.3 - $78.44 $384 Million - $600 Million
7,644,130 New
7,644,130 $600 Million

Others Institutions Holding DNLI

# of Institutions
228
Shares Held
120M
Call Options Held
60.6K
Put Options Held
48.4K
View Full List

About Denali Therapeutics Inc.

DNLI Quotes by TradingView
  • Ticker DNLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 134,174,000
  • Market Cap $3.28B
  • Description
  • Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...
More about DNLI
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email